baber/WOPTO huggingface dataset:
Patent FI-952274-A0 (FI)
Inventor: COUTURE PIERRE
IPC: B60L50/15
Filed: 1995-05-10
Abstract: The motor vehicle drive system is for a motor vehicle having an electric motor system, an actuating system, an accelerator system, a mode selector and a battery. The drive system comprises a power supply bus having an output for supplying the electric motor system; a battery connector for connection to the battery, the connector having a power output for supplying the power supply bus; a controller system having inputs respectively for connection to the components of the vehicle so that it can monitor their status; a power converter system connected to the power supply bus of the controller system, and to the motor system for supplying it; a combustion motor electric power supply having an input connected to the controller system, and an output for producing current; a first power converter having an input connected to the power supply, and an output for supplying the power supply bus, the controller system being connected to the power converter so that it is monitored and controlled by the controller system, whereby the controller system monitors and controls operation of the electric motor system and, when auxiliary electric power is needed on the power supply bus, the controller system activates operation of the combustion power supply.
Patent FI-954882-A0 (FI)
Inventor: FJALLSTROM ROLAND
IPC: D21B1/32
Filed: 1995-10-13
Abstract: An apparatus for treating a pulp slurry of waste paper including long fibers, short fibers and large and fine impurities includes the step of spraying the slurry through a gaseous medium upon a screen to separate long fibers and large impurities from small fibers and fine impurities.
Patent FI-960410-A0 (FI)
Inventor: FOELIX HEINRICH
IPC: B66B5/00
Filed: 1996-01-30
Abstract: The hoist shaft (2) is accessible via a door (17). A set-down mechanism (28) has at least one swivelling buffer (8) which automatically moves from a pulled-back position into a securing position defining the access to the cabin (1). The buffer is preferably automatically tilted by gravity into the securing position, and retracted by an actuator (12) into the pulled-back position. The securing position is signalled by a safety switch (13) operated by the actuator which is de-activated when the shaft door is opened when the cabin is absent.
Patent FI-962550-A0 (FI)
Inventor: HOFFMAN HANS-RAINER
IPC: A61K31/135
Filed: 1996-06-19
Abstract: PCT No. PCT/EP94/04047 Sec. 371 Date Aug. 15, 1996 Sec. 102(e) Date Aug. 15, 1996 PCT Filed Dec. 6, 1994 PCT Pub. No. WO95/17188 PCT Pub. Date Jun. 29, 1995A drug for the release of active substances to the skin, which has an increased deuterium portion as compared to the natural isotope distribution.
Patent FI-962882-A0 (FI)
Inventor: NEWMAN THOMAS H
IPC: C08F12/00
Filed: 1996-07-17
Abstract: A process for preparing titanium or zirconium hydrocarbyloxide complexes in a reduced oxidation state comprising contacting the corresponding complex in an elevated oxidation state with lithium alkyl reducing agent and recovering the resulting product.
Patent FI-973888-A0 (FI)
Inventor: MARTTILA TOM
IPC: C25C7/02
Filed: 1997-10-06
Abstract: The invention relates to an electrode for electrolytic refining or electrowinning, said electrode (1, 21, 41) being provided with a hanger bar (3, 23, 43) attached to the edge of one plate-like mother plate, and the edges (4, 5, 6; 24, 30, 31; 44, 49, 50) of said electrode, apart from the edge to which the hanger bar is fastened, being protected with an edge strip (11, 12, 13; 29, 32, 33; 48, 51, 52) made of some insulating material, in which electrode at least part of the edge strips is at least partly placed in a groove (7, 25, 45) made in the electrode edge. According to the invention, at least in one electrode edge (4, 5, 6; 24, 30, 31; 44, 49, 50), there is formed a groove (7, 25, 45) for the electrode edge strip (11, 12, 13; 29, 32, 33; 48, 51, 52) made of some insulating material; the front end of said groove, located at the electrode edge (4, 5, 6; 24, 30 31; 44, 49, 50), being essentially equal in width with the rear end (10, 28, 53) of the groove placed inside the electrode. The invention also relates to a method for manufacturing the electrode (1, 21, 41).
Patent AP-9701146-A0 (AP)
Title: Fused bicyclic pyrimidine derivatives.
Inventor: ARNOLD LEE DANIEL
IPC: A61K/
Filed: 1997-11-20
Abstract: The invention relates to compunds of the formula (i)and to pharmaceutically acceptable salts thereof, wherein r1, r2 and z are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula i and to methods of using said compounds in the treatment of hyperproliferative diseases such as cancer.
Patent IL-58918-A0 (IL)
Title: 7,8,9,10-tetrahydrothieno (3,2-e) pyrido (4,3-b)-indole compounds their production and pharmaceutical compisitions containing them
IPC: A61P25/24
Filed: 1979-12-11
Abstract: The present invention relates to certain new 7,8,9,10-tetrahydrothieno[3,2-e]pyrido[4,3-b]indole compound, to a process for their production and to their use as agents which have an influence on the central nervous system. The ring system according to the invention has not hitherto been described in the literature.
Patent IL-74594-A0 (IL)
Title: Coated oxidation-resistant porous abrasive compact and method for making same
IPC: B24D18/00
Filed: 1985-03-14
Abstract: Disclosed is an improved polycrystalline compact of self-bonded diamond particles having a network of interconnected empty pores dispersed throughout. The improved porous polycrystalline diamond compact possesses enhanced oxidation resistance and comprises all of the exterior surfaces of the porous compact being enveloped with a continuous coating which is effective under metal bond fabrication conditions so that oxidation of the diamond in the compact does not exceed a threshold level whereat loss of diamond properties of the compact occurs. Metal bond fabrication conditions comprehend an atmosphere containing oxygen or water vapor. Metal coatings are preferred, especially in coating thicknesses in excess of about 30 microns.
Patent IL-76106-A0 (IL)
Title: Method for culturing microorganisms
IPC: C12N1/38
Filed: 1985-08-15
Abstract: The culturing of microorganisms in a nutrient medium is improved by adding a zeolite to the nutrient medium. The zeolites can be synthetic or natural.
Patent IL-88348-A0 (IL)
Title: Multifocal optical device with novel phase zone plate
IPC: G02B5/18
Filed: 1988-11-10
Abstract: A diffractive multifocal optical element comprising a phase zone plate of a Cohen lens design containing rotationally symmetrical, curved repetitive patterns designed to operate at a specific wavelength and which are also curved in r<2> space.
Patent IL-91243-A0 (IL)
Title: 2-amino-4-morpholino-6-propyl-1,3,5-triazines,their preparation and pharmaceutical compositions containing them
IPC: A61P21/02
Filed: 1989-08-08
Abstract: New 2-amino-4-morpholino-6-propyl-1,3,5-triazines having the formula <IMAGE>  (I)  wherein R1 is hydrogen, alkyl, aralkyl or acetyl, R2 is hydroxyl, hydroxyalkyl, alkoxyalkyl, dialkylamino, arylhydroxyalkyl, (hydroxy-cycloalkyl)alkyl, alkanoyloxyalkyl, benzoyloxyalkyl, phenylacetyloxyalkyl, aminocarbonyloxyalkyl, COR3 or CONR4R5, or NR1R2=(hydroxyalkyl)alkyleneimino, R3=alkyl, aryl, haloaryl, alkylaryl, alkoxyaryl, aralkyl or aryloxy, R4=R5=hydrogen or alkyl, alkyl, alkoxy and alkanoyloxy having 1 to 4 carbon atoms, cycloalkyl and alkyleneimino having 4 to 6 carbon atoms. Moreover, when R1 is acetyl, R2 is acetoxyalkyl. Processes for the preparation thereof and pharmaceutical compositions containing the same are also given. In particular, these compounds are useful for the treatment of cognitive and behavioral disorders associated with aging and dementia syndromes, e.g. those associated with Alzheimer's disease.
Patent IL-93527-A0 (IL)
Title: Bacteriocin compositions
IPC: A01N63/50
Filed: 1990-02-26
Abstract: Broad range bacteriocin compositions are provided. The compositions can be dissolved or suspended in a suitable solvent or matrix and are more active towards a broader range of bacteria than are any of the component parts. The dissolved or suspended compositions constitute enhanced broad range bactericides. The compositions include lysostaphin and a lanthionine containing peptide bacteriocin; lysostaphin, a lanthionine containing peptide bacteriocin and a chelating agent; and lysostaphin, a lanthionine containing peptide, a chelating agent and a surfactant. Each component is present in the enhanced broad range bactericide in sufficient amount such that the bactericide is more effective against staphylococci than is lysostaphin alone and is more effective at treating and preventing a broad range of microbial infections. Methods of treating bacterial infections using said compositions and bactericides are provided.
Patent IL-99146-A0 (IL)
Title: Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IPC: C07D413/04
Filed: 1991-08-09
Abstract: The present invention relates to therapeutically active azacyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
Patent AU-PR064800-A0 (AU)
Title: Improved membrane filtration system
IPC: B01D61/14
Filed: 2000-10-09
Abstract: A method and apparatus for reducing volume of feed liquid required in a porous membrane filtration system having a number of porous hollow fibre membranes submersed in a volume of feed liquid to be filtered, the method comprising the step of providing filter elements within said volume of feed liquid to be filtered.
Patent FI-20002770-A0 (FI)
Inventor: KARJANLAHTI JUHA
IPC: H04L45/16
Filed: 2000-12-18
Abstract: An IP-based group communication feature in a mobile communication network is based on the pre-established logical connections established between a gateway node (GGSN) and members of a group in the mobile communication network. No separate call establishment procedures using VoIP signaling are used for connecting a user equipment (UE) logically to group(s), but the procedure is preferably based on the normal logical connection establishment signaling (e.g. PDP context creation) as used for data service. The UE implements a host supporting the IP multicasting, and the next IP layer peer for the UE host is located in the gateway node. The gateway node provides an IP interface towards an external multicast router so that the UE host looks like a normal IP host supporting IP multicasting. The IP-based voice traffic is mapped and transferred over pre-established connections between the gateway and the UEs of the specific group.
Patent FI-20031267-A0 (FI)
Inventor: PIIPPO ANTTI
IPC: H02P25/02
Filed: 2003-09-05
Abstract: A method for determining the speed and position of a rotor of a salient-pole permanent magnet synchronous machine, the method comprising the steps of creating a voltage model (41) on a permanent magnet synchronous machine, forming a voltage reference (u s,ref ) for a stator of the permanent magnet synchronous machine, determining stator currents (i s ) of the permanent magnet synchronous machine, calculating a rotor angular speed (42) from the voltage reference (u s,ref ) and the stator currents (i s ) using the voltage model (41). The method further comprises the steps of forming with signal injection a position tracking signal (µ)of the rotor of the permanent magnet synchronous machine, forming a rotor angular speed estimate ( É    m  )from the calculated rotor angular speed (42) and the rotor position tracking signal (µ), forming a rotor position angle estimate (¸   m  ) from the formed rotor angular speed estimate (É   m  ) and the rotor position tracking signal (µ).
Patent IL-112348-A0 (IL)
Title: 3-Amino-2-phenyl- piperidine and (2s, 3s)-3-amino-2-phenylpiperidine
Inventor: DESAI MANOJ C
IPC: A61P17/00
Filed: 1995-01-16
Abstract: 3-Amino-2-phenylpiperidine is a valuable intermediate for the preparation of certain 3-aminopiperidine substance P antagonists. (Divisional of application no 90313680.2).
Patent IL-128263-A0 (IL)
Title: Filtering devices and cartridges for fluids
IPC: B01D53/04
Filed: 1999-01-28
Abstract: The invention provides a solid filter body (4) for a filter unit, including a sintered composition of adsorbing materials containing activated carbon having a particle size in the range of from 4 to 100 mesh, and a binder in the form of thermoplastic powder having a particle size in the range of from 10 to 250 mesh, the ratio of binder to adsorbent being less than 25% by weight, and the composition being sintered at a temperature below 250 DEG C. The invention further provides a fluid filter unit (2) including a casing (6) having inlet and outlet openings (8, 10) housing the solid filter body (4) and a method for manufacturing the solid filter body. <IMAGE>
Patent IL-129038-A0 (IL)
Title: Quinazoline derivatives and pharmaceutical compositions containing them
IPC: A61P37/00
Filed: 1997-09-23
Abstract: 4-Anilino-quinazoline derivatives of formula (I) and their salts are new. m = 1 or 2; R1 = H, OH, halo, NO2, CF3, CN, 1-3C alkyl, alkoxy, or alkylthio, or NR5R6; R2 = H, OH, halo, MeO, amino, or NO2; R3 = OH, halo, 1-3C alkyl, alkoxy, or alkanoyloxy, CF3, CN, amino, or NO2; X1 = O, CH2, S, SO, SO2, NR7CO, CONR8, SO2NR9, NR10SO2, or NR11; R5, R6 = H or 1-3C alkyl; R7-R11 = H, 1-3C alkyl, or 1-3C alkoxy(2-3C alkyl); R4 = WR12 (linked through a C atom of R12), WR13, (2-5C alkenylene)-R14, (2-5C alkynylene)-R15, W-X2-W-X3-R16, W-X4-COR22, W-X5-R27, W-X6-W-R33, R39, W-R40, W-R43, or W-R44; when X1 = O, S, SO, or SO2, then R4 can also = 1-3C alkoxy 2-4C alkyl; when X1 = O, then R4 can also = 1-4C alkyl; and provided that, when R4 = W-X2-W-X3-R16, then X1 is not CH2; W = 1-5C alkylene; X2, X3 = as X1, but not CH2; X4 = O or NR23; X5 = OCO, or as X1, but not CH2; X6 = as X1, but not CH2; R12, R14, R15 = Het; Het = 5 or 6 membered saturated heterocyclyl, containing 1 or 2 heteroatoms from O, S, N (optionally containing 1 or 2 substituents G); G = oxo, OH, halo, 1-4C alkyl, alkoxy, or hydroxyalkyl, 1-4C alkanoyl, 2-5C alkoxycarbonyl, carbamoyl, or mono- or di- (1-4C alkyl)carbamoyl; R13 = pyrrolidin-1-yl, imidazolidin-1-yl, or thiomorpholinyl (optionally containing 1 or 2 substituents G); R16 = H or 1-3C alkyl; R22 = NR24R25 or OR26; R23-R26 = as R7; R27, R33 = cyclopentyl, cyclohexyl, or Het (all optionally containing 1 or 2 substituents G), or 1-3C alkyl; provided that, when R27 = 1-3C alkyl, then X5 is a group containing S, and X1 is not CH2; R39 = pyrrolidin-3-yl, piperidin-3-yl, or piperidin-4-yl (all optionally containing 1 or 2 substituents G); R40 = piperazin-1-yl (substituted by 1 or more 1-4C alkanoyl or hydroxyalkyl, 2-5C alkoxycarbonyl, or CONR41R42); R41, R42 = H or 1-4C alkyl; R43 = morpholinyl (optionally containing 1 or 2 substituents G); and R44 = morpholinyl (substituted by at least one, and optionally 2, G); provided that when R4 = alkoxyalkyl or alkyl then R1 and/or R2 = NO2 or \- 1 R3 = 1-3C alkanoyloxy.
Patent IL-134191-A0 (IL)
Title: Composition and method for treating penile erectile dysfunciton
IPC: A61K31/50
Filed: 1998-06-15
Abstract: A composition for the topical transdermal administration to the penis is based on prostaglandin E1. The composition is non-irritating and effective for relieving erectile impotence or other penile erectile dysfunction. A penetration enhancing effective amount of a dioxolane, dioxane, or acetal skin penetration enhancing compound in a pharmaceutically acceptable aqueous alcoholic carrier is used to facilitate the penetration of the prostaglandin E1 active ingredient through the skin. Phentolamine or prazosin may be used in combination with prostaglandin E1.
Patent IL-137286-A0 (IL)
Title: A new method for manufacturing popping candy
IPC: A23G3/00
Filed: 1998-11-05
Abstract: This invention is related to a reactor used in the production of hard candy by employing a treatment with neutral carbon dioxide gas and thus having gas bubbles, which effervesce in the mouth. The reactor for manufacturing popping candy includes a pressure vessel of double-walled construction; a shaft assembly mounted within the pressure vessel for rotation about a longitudinal axis of the pressure vessel; the shaft assembly including a first shaft located within a second shaft for circulation of cooling fluid in the shaft assembly; a plurality of stirring blades secured to the second shaft and arranged at an angle to the longitudinal axis; and a reactor wall stripper attached to outer ends of the blades, the reactor wall stripper having a width substantially identical to widths of the blades.
Patent IL-143403-A0 (IL)
Title: Methods and compositions for treating disorders involving excitotoxicity
IPC: A61P25/04
Filed: 1999-12-03
Abstract: It is shown here that hedgehog polypeptides possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14.5 (E14.5) rat ventral mesencephalon, we show that hedgehog is also trophic for dopaminergic neurons and other neurons which are sensitive to exotoxicity.
Patent IL-145142-A0 (IL)
Title: Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
IPC: C12N15/12
Filed: 2000-03-01
Abstract: The invention provides a recombinant vector comprising an ovine adenovirus genome and a sequence encoding a heterologous polypeptide, wherein the sequence encoding the heterologous polypeptide is inserted between E4 and E3 transcription units of the ovine adenovirus genome.
Patent IL-152270-A0 (IL)
Title: Method and system for expanding the data payload of data messages transported via a cellular network control channel
IPC: H04B7/26
Filed: 2001-04-13
Abstract: A mobile station issues a Call Origination signal. The mobile radiotelephone that has the capability of inserting data content within the dialed digits field of the conventional Call Origination signal. In response to receiving the Call Origination signal, the MSC determines that this mobile station is associated with a "foreign" gateway and issues an Origination Request message to a visitor location register system ("VLR"). The MSC issues a Origination Request message rather than a Qualification Request message because of the prior setting of one or more appropriate call processing trigger(s) at the switch. The MSC/VLR forwards the Origination Request message to the distant gateway or home location register ("HLR") associated with the identified mobile station. The HLR issues an Origination Request RETURN RESULT with the Authorization Denied parameter.
Patent IL-154107-A0 (IL)
Title: Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
IPC: C07D491/04
Filed: 2001-07-25
Abstract: Aminopiperidine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man
Patent IL-174313-A0 (IL)
Title: Millimetre and sub-millimetre imaging device
IPC: G01V8/00
Filed: 2006-03-14
Abstract: The terahertz camera has a fixed objective lens and a plurality of detectors positioned at the focal plane of the objective lens. Each of the detectors is mounted on a movable support so that the antenna is capable of movement across the focal plane of the objective lens and is provided with a flexible waveguide for connecting the output of the detector with signal processing means. Each detector is also provided with a retroreflector which is reflective at frequencies other than terahertz frequencies. During use of the camera, the retroreflector of each detector is illuminated at non-terahertz frequencies so that the spatial position of each detector and hence the spatial source of signals generated by the detector can be accurately identified. The terahertz camera is particularly suited for use in security installations and in chemical and food processing industries.
Patent IL-175906-A0 (IL)
Title: Anti-vegf antibodies
IPC: C12N15/13
Filed: 2006-05-24
Abstract: Humanized and variant anti-VEGF antibodies and various uses therefore are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells  in vitro,  and inhibit tumor growth  in vivo.
Patent IL-180385-A0 (IL)
Title: Ice-containing products
IPC: A23L23/00
Filed: 2006-12-27
Abstract: A method is provided for producing an ice-containing product which method comprises in the following order: (i) cooling a product concentrate to a temperature of below -4° C.; (ii) combining the cooled concentrate with frozen particles, a substantial proportion of which have a particle size of greater than 5 mm; and (iii) mechanically reducing the size of the frozen particles such that substantially all of the resulting frozen particles have a size of greater than 0.5 mm and less than 5 mm.
Patent IL-181117-A0 (IL)
Title: Sustained drug release composition demonstrating an ascending zero order release pattern, methods of manufacturing such a composition
Filed: 2007-02-01
Abstract: Disclosed are dosage forms and methods for sustained release of a drug including: a delay layer comprising a polymeric matrix, and microencapsulated drug, wherein the delay layer is substantially free of non-microencapsulated drug; and a second layer including a polymeric matrix, and non-microencapsulated drug matrix; wherein the second layer is located adjacent to the delay layer.
Patent IL-196048-A0 (IL)
Title: Method and apparatus for producing decabromodiphenyl alkanes
IPC: B01J8/02
Filed: 2008-12-18
Abstract: A method of producing decabromodiphenyl alkanes includes the steps of charging a reaction vessel with bromine and a bromination catalyst and introducing a diphenyl alkane into the vessel at a location above the level of the charge bromine and catalyst. A dip tube apparatus for introducing the diphenyl alkane includes an inner tube and an outer tube, each of which are disposed above the surface of the bromine reaction vessel. The inner tube is fitted with a plug having an opening. Diphenyl alkane flows through the inner tube, out the opening in the plug, and into the reactor. The outer tube is disposed around and along the inner tube. Reaction mass from the vessel is recirculated from the vessel, through the outer tube and back to the vessel so as to form a curtain of reaction mass around the stream of diphenyl alkane being simultaneously fed into the reaction vessel.
Patent RO-132466-A0 (RO)
Title: Breath-monitoring device
Inventor: BEŞLEAGĂ STAN CRISTINA
IPC: A61B5/087
Filed: 2017-10-20
Abstract: The invention relates to an electronic breath-monitoring device meant to be used in the medical field, for treating respiratory sy stem diseases such as apnea and for surveying the health condition of elderly people. According to the invention, the device consists of an IGZO-based thin-film transistor which detects the breath when it is placed in the path of the exhaled air, at a distance of few centimeters, because the exhaled air, charged with water vapours, influences the drain and gate currents through the transistor.
Patent MA-23024-A1 (MA)
Inventor: MICHEL DE MINAC
IPC: C13B10/00
Filed: 1993-11-04
Abstract: PCT No. PCT/FR93/01089 Sec. 371 Date May 5, 1995 Sec. 102(e) Date May 5, 1995 PCT Filed Nov. 4, 1993 PCT Pub. No. WO94/10862 PCT Pub. Date May 26, 1994Method for producing sugar, characterized in that a polyether ionophore antibiotic is used to suppress gram positive bacteria growth during the process.